FGFR3 Gene Achondroplasia Genetic Test
Test Name: FGFR3 Gene Achondroplasia Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for FGFR3 Gene Achondroplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR3 Gene Achondroplasia NGS Genetic DNA Test gene FGFR3
Test Details
Achondroplasia is a genetic disorder that affects bone growth and development, resulting in dwarfism. It is caused by a mutation in the FGFR3 gene, which encodes a protein involved in regulating bone growth.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of achondroplasia, NGS genetic testing can be used to identify mutations in the FGFR3 gene that are associated with the disorder.
NGS genetic testing for achondroplasia involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the FGFR3 gene to identify any mutations or variations. This can help confirm a diagnosis of achondroplasia and provide information about the specific mutation involved.
NGS genetic testing for achondroplasia can be useful for individuals who have symptoms consistent with the disorder, as well as for carrier testing in individuals with a family history of achondroplasia. It can also be used for prenatal testing to determine if a fetus has inherited the mutation and is at risk for developing achondroplasia.
It’s important to note that genetic testing for achondroplasia is a personal decision and should be discussed with a healthcare professional or genetic counselor, who can provide guidance and support throughout the testing process.
| Test Name | FGFR3 Gene Achondroplasia Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for FGFR3 Gene Achondroplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR3 Gene Achondroplasia NGS Genetic DNA Test gene FGFR3 |
| Test Details |
Achondroplasia is a genetic disorder that affects bone growth and development, resulting in dwarfism. It is caused by a mutation in the FGFR3 gene, which encodes a protein involved in regulating bone growth. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of achondroplasia, NGS genetic testing can be used to identify mutations in the FGFR3 gene that are associated with the disorder. NGS genetic testing for achondroplasia involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the FGFR3 gene to identify any mutations or variations. This can help confirm a diagnosis of achondroplasia and provide information about the specific mutation involved. NGS genetic testing for achondroplasia can be useful for individuals who have symptoms consistent with the disorder, as well as for carrier testing in individuals with a family history of achondroplasia. It can also be used for prenatal testing to determine if a fetus has inherited the mutation and is at risk for developing achondroplasia. It’s important to note that genetic testing for achondroplasia is a personal decision and should be discussed with a healthcare professional or genetic counselor, who can provide guidance and support throughout the testing process. |
